✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Here, we present a case of GBS occurring after COVID-19, accompanied by dysautonomia.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The COVID-19 pandemic that emerged in Wuhan, Hubei Province, China in December 2019 is ongoing.
📊
Key Findings & Data:COVID-19 may also cause neurological symptoms with central or peripheral nervous system or skeletal muscle involvement.
💡
Conclusion & Impact:Here, we present a case of GBS occurring after COVID-19, accompanied by dysautonomia.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters
Abstract
The COVID-19 pandemic that emerged in Wuhan, Hubei Province, China in December 2019 is ongoing. COVID-19 may also cause neurological symptoms with central or peripheral nervous system or skeletal muscle involvement. Guillain–Barré syndrome (GBS) is an autoimmune disorder of the peripheral nervous system that is usually triggered by bacterial or viral infections. Autonomic nerve involvement can be seen in GBS. Case reports suggest that GBS is linked to COVID-19 infection. Here, we present a case of GBS occurring after COVID-19, accompanied by dysautonomia.
🔖
Cite This Article
TECELLİOĞLU, M., ÖZCAN, C. (2022). Guillain-Barré Syndrome after COVID-19 accompanied byDysautonomia. Annals of Medical Research, Cilt: 28 - Sayı: 7, 1426–1429. https://ajindex.com/articles/445782